001     858528
005     20210130000010.0
024 7 _ |a 10.1002/cbic.201800673
|2 doi
024 7 _ |a 1439-4227
|2 ISSN
024 7 _ |a 1439-7633
|2 ISSN
024 7 _ |a pmid:30537293
|2 pmid
024 7 _ |a WOS:000462914700013
|2 WOS
024 7 _ |a altmetric:55770688
|2 altmetric
024 7 _ |a 2128/23484
|2 Handle
037 _ _ |a FZJ-2018-07399
082 _ _ |a 540
100 1 _ |a Aschenbrenner, Jennifer
|0 P:(DE-Juel1)166535
|b 0
245 _ _ |a Microbial production of natural and non‐natural monolignols with Escherichia coli
260 _ _ |a Weinheim
|c 2019
|b Wiley-VCH
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1564465610_18806
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Biotechnologie 1
520 _ _ |a Phenylpropanoids and phenylpropanoid‐derived plant polyphenols find numerous applications in the food and pharmaceutical industries. In recent years, several microbial platform organisms have been engineered towards producing such compounds. However, for the most part, microbial (poly)phenol production is inspired by nature, so naturally occurring compounds have predominantly been produced to date.Here we have taken advantage of the promiscuity of the enzymes involved in phenylpropanoid synthesis and exploited the versatility of an engineered Escherichia coli strain harboring a synthetic monolignol pathway to convert supplemented natural and unnatural phenylpropenoic acids into their corresponding monolignols. The performed biotransformations showed that this strain is able to catalyze the stepwise reduction of chemically interesting unnatural phenylpropenoic acids such as 3,4,5‐trimethoxycinnamic acid, 5‐bromoferulic acid, 2‐nitroferulic acid, and a “bicyclic” p‐coumaric acid derivative, in addition to six naturally occurring phenylpropenoic acids.
536 _ _ |a 583 - Innovative Synergisms (POF3-583)
|0 G:(DE-HGF)POF3-583
|c POF3-583
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Marx, Patrick
|0 P:(DE-Juel1)168363
|b 1
700 1 _ |a Pietruszka, Jörg
|0 P:(DE-Juel1)128906
|b 2
|u fzj
700 1 _ |a Marienhagen, Jan
|0 P:(DE-Juel1)144031
|b 3
|e Corresponding author
773 _ _ |a 10.1002/cbic.201800673
|g p. cbic.201800673
|0 PERI:(DE-600)2020469-3
|n 7
|p 949-954
|t ChemBioChem
|v 20
|y 2019
|x 1439-7633
856 4 _ |u https://juser.fz-juelich.de/record/858528/files/Aschenbrenner%20J.%20et%20al%20ChemBioChem%2020%20949-954.pdf
|y Restricted
856 4 _ |x pdfa
|u https://juser.fz-juelich.de/record/858528/files/Aschenbrenner%20J.%20et%20al%20ChemBioChem%2020%20949-954.pdf?subformat=pdfa
|y Restricted
856 4 _ |y Published on 2018-12-11. Available in OpenAccess from 2019-12-11.
|u https://juser.fz-juelich.de/record/858528/files/Aschenbrenner%20Monolignole%202019%20incl.%20Supplements.pdf
856 4 _ |y Published on 2018-12-11. Available in OpenAccess from 2019-12-11.
|x pdfa
|u https://juser.fz-juelich.de/record/858528/files/Aschenbrenner%20Monolignole%202019%20incl.%20Supplements.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:858528
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)168363
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)128906
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)144031
913 1 _ |a DE-HGF
|b Key Technologies
|l Key Technologies for the Bioeconomy
|1 G:(DE-HGF)POF3-580
|0 G:(DE-HGF)POF3-583
|2 G:(DE-HGF)POF3-500
|v Innovative Synergisms
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CHEMBIOCHEM : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBG-1-20101118
|k IBG-1
|l Biotechnologie
|x 0
920 1 _ |0 I:(DE-Juel1)IBOC-20090406
|k IBOC
|l Institut für Bioorganische Chemie (HHUD)
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBG-1-20101118
980 _ _ |a I:(DE-Juel1)IBOC-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21